ATR and breast carcinoma: The xCELLigence RTCA S16 real-time cell analysis system (Acea Biosciences, San Diego, CA, USA) was used to investigate in detail the anti-proliferative effect of the ATR molecule on MDA-MB-231 and BT-474 breast cancer and normal breast cells.